State Street Corp Raises Holdings in Renovaro Inc. (NASDAQ:RENB)

State Street Corp boosted its stake in shares of Renovaro Inc. (NASDAQ:RENB) by 3.8% in the third quarter, Holdings Channel reports. The institutional investor owned 1,323,832 shares of the company’s stock after acquiring an additional 48,114 shares during the period. State Street Corp’s holdings in Renovaro were worth $640,000 as of its most recent SEC filing.

Separately, Rhumbline Advisers bought a new stake in Renovaro during the second quarter valued at about $79,000. 71.41% of the stock is currently owned by institutional investors and hedge funds.

Renovaro Stock Performance

Shares of Renovaro stock opened at $0.93 on Friday. Renovaro Inc. has a one year low of $0.40 and a one year high of $5.25. The company has a market capitalization of $146.97 million, a PE ratio of -0.96 and a beta of 0.65. The company has a 50-day simple moving average of $0.92 and a two-hundred day simple moving average of $0.90.

Renovaro (NASDAQ:RENB) last released its quarterly earnings results on Thursday, October 10th. The company reported ($0.45) earnings per share (EPS) for the quarter.

Renovaro Profile

Renovaro Inc, a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company’s product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV.